| Fibroblast growth factor receptor 1 gene amplification and protein expression in human lung cancer O Elakad, AM Lois, K Schmitz, S Yao, S Hugo, L Lukat, M Hinterthaner, ... Cancer Medicine 9 (10), 3574-3583, 2020 | 17 | 2020 |
| One carbon metabolism in human lung cancer S Yao, L Peng, O Elakad, S Küffer, M Hinterthaner, BC Danner, ... Translational lung cancer research 10 (6), 2523, 2021 | 16 | 2021 |
| Activation of CD44/PAK1/AKT signaling promotes resistance to FGFR1 inhibition in squamous-cell lung cancer O Elakad, B Häupl, V Labitzky, S Yao, S Küffer, ... NPJ Precision Oncology 6 (1), 52, 2022 | 8 | 2022 |
| Role of annexin A1 in squamous cell lung cancer progression O Elakad, Y Li, N Gieser, S Yao, S Küffer, M Hinterthaner, BC Danner, ... Disease Markers 2021, 1-10, 2021 | 6 | 2021 |
| UDP-glucose 6-dehydrogenase expression as a predictor of survival in patients with pulmonary adenocarcinoma S Saha, S Yao, O Elakad, AM Lois, H Henric-Petri, J Buentzel, ... IJS Oncology 5, e851-e855, 2020 | 5 | 2020 |
| Expression and prognostic impact of alpha thalassemia/mental retardation X-linked and death domain-associated protein in human lung cancer J Buentzel, S Yao, O Elakad, AM Lois, J Brünies, J König, M Hinterthaner, ... Medicine 98 (31), e16712, 2019 | 5 | 2019 |
| Proteomic profiling of cisplatin-resistant and cisplatin-sensitive germ cell tumour cell lines using quantitative mass spectrometry A Fichtner, H Bohnenberger, O Elakad, A Richter, C Lenz, C Oing, ... World Journal of Urology 40 (2), 373-383, 2022 | 4 | 2022 |
| Low expression of CD24 is associated with poor survival in colorectal cancer S Nersisyan, AK Ahlers, T Lange, D Wicklein, A Galatenko, ... Biochimie 192, 91-101, 2022 | 4 | 2022 |
| Regulation and therapeutic targeting of MTHFD2 and EZH2 in KRAS-mutated human pulmonary adenocarcinoma Y Li, O Elakad, S Yao, A von Hammerstein-Equord, M Hinterthaner, ... Metabolites 12 (7), 652, 2022 | 3 | 2022 |
| Expression and prognostic impact of CD49b in human lung cancer A Tirilomi, O Elakad, S Yao, Y Li, M Hinterthaner, BC Danner, P Ströbel, ... Medicine 101 (6), e28814, 2022 | 3 | 2022 |
| Enhancer of zeste homolog 2 (EZH2) is a marker of high-grade neuroendocrine neoplasia in gastroenteropancreatic and pulmonary tract and predicts poor prognosis SCB Bremer, G Bittner, O Elakad, H Dinter, J Gaedcke, AO König, ... Cancers 14 (12), 2828, 2022 | 2 | 2022 |
| Spontaneous metastasis xenograft models link CD44 isoform 4 to angiogenesis, hypoxia, EMT and mitochondria‐related pathways in colorectal cancer A Everest‐Dass, S Nersisyan, H Maar, V Novosad, J Schröder‐Schwarz, ... Molecular Oncology 18 (1), 62-90, 2024 | 1 | 2024 |
| Expression and prognostic impact of DNA-PK in human lung cancer A Tirilomi, O Elakad, S Yao, Y Li, M Hinterthaner, BC Danner, P Ströbel, ... Medicine 102 (9), e33143, 2023 | | 2023 |
| EZH2 is ein Marker für high-grade neuroendokrine Neoplasien des GI-Trakts und der Lunge und ist mit einer schlechte Prognose assoziiert S Bremer, G Bittner, O Elakad, H Dinter, J Gaedcke, A König, A Amanzada, ... Zeitschrift für Gastroenterologie 60 (08), KA497, 2022 | | 2022 |
| Functional and diagnostic relevance of FGFR1-dependent signaling pathways in squamous cell lung cancer O Elakad Georg-August-Universität Göttingen, 2020 | | 2020 |
Hanibal BohnenbergerInstitute of Pathology, University Medical Center Göttingen, GermanyDirección de correo verificada de med.uni-goettingen.de
